Medical Cannabis and Cannabinoids

Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), announces that it has closed its previously-announced transactions to acquire Utah-based WholesomeCo Cannabis (“Wholesome”) and the Arches proprietary technology and analytics platform. Wholesome is a dominant player in the Utah medical market, fueled by a large delivery operation with one single dispensary. The company […]

MariMed Inc. (“MariMed,” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announces it has completed its acquisition of First State Compassion Center (“FSCC”), the leading cannabis operator in Delaware, in accordance with the terms of the previously announced Omnibus Agreement entered into with FSCC in July 2023. The acquisition integrates FSCC’s

Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), announces that it has signed three definitive documents and one binding Memorandum of Understanding (“MOU”) to acquire four single-state operators for total consideration of approximately $397 million in a series of all-stock transactions (collectively, the “Merger Transactions”). Vireo has signed definitive agreements to acquire

MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company’s cannabis portfolio globally. With these recent acquisitions, MedCana has rapidly solidified its position as a leading force in the Cannabis industry. Read the

Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach to impact investing, announced the sale of its cannabinoid drug development business as part of its strategic plan to focus on acquiring, reclaiming and